Skip to main content

IGM Biosciences, Inc.

IGMSDelisted Aug 14, 2025
Industry
Pharmaceutical Preparations
SEC CIK
0001496323

IGM Biosciences, Inc. was delisted on Aug 14, 2025; its insiders filed their last Form 4 on Aug 18, 2025; 66 institutions reported holding it in 13F filings for Q2 2025, worth $17.9M in total; no superinvestor held it.

Q4 2021 vs. Q3 2021

How the institutions holding IGM Biosciences, Inc. changed between Q3 2021 and Q4 2021.

All holders in Q4 2021All holders in Q3 2021

13F holders of IGMS: Q3 2021 compared with Q4 2021
MeasureQ3 2021Q4 2021Change
Holders10787−20
Shares16.9M17.6M+739.6K (+4.4%)
Value$1.11B$517.3M−$594.0M (−53.4%)

New holders (13)

Institutions that held IGM Biosciences, Inc. at the end of Q4 2021 but not at the end of Q3 2021.

Institutions new to IGMS in Q4 2021
InstitutionSharesValue% of portfolio
Voloridge Investment Management, LLC97,474$2.86M0.02%
Entrust Global Partners L L C66,172$1.94M0.54%
Walleye Capital LLC35,127$1.03M0.03%
Qube Research & Technologies Ltd32,202$944.0K0.01%
Two Sigma Advisers, LP22,600$663.0K0.00%
Renaissance Technologies LLC12,500$367.0K0.00%
HRT Financial LP12,162$356.0K0.00%
Putnam Investments LLC10,133$297.0K0.00%
Squarepoint Ops LLC9,265$272.0K0.00%
Point72 Hong Kong Ltd1,149$34.0K0.00%
Tarbox Family Office, Inc.22$1.00K0.00%
Dark Forest Capital Management LP7$00.00%
Covestor Ltd8$00.00%

Sold out (33)

Institutions that held IGM Biosciences, Inc. at the end of Q3 2021 and filed for Q4 2021 without it.